In Vivo and in Vitro Study of Several Pharmacodynamic Effects of Meropenem

References

• Bigger JW. The bactericidal action of penicillin on Staphylococcus pyogenes. Irish J Med Sci 1944; 227: 533–568
   Google Scholar
• Hesen MT., Pitsakis PG., Levison ME. Absence of postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin. J Infect Dis 1988; 158: 542–548
   PubMed Web of Science ®Google Scholar
• Odenholt I, Holm SE., Cars O. Effects of supra and sub-MIC benzylpenicillin concentrations on group A β-haemolytic streptococci during the postantibiotic phase in vivo. J Antimicrob Chemother 1990; 26: 193–201
   PubMed Web of Science ®Google Scholar
• Gudmundsson S, Vogelman B, Craig WA. The in vivo postantibiotic effect of imipenem and other new antimicrobials. J Antimicrob Chemother 1986; 18(Suppl E)67–73
   PubMedGoogle Scholar
• Craig WA., Redington J, Ebert SC. Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections. J Antimicrob Chemother 1991; 27(Suppl C)29–40
   PubMedGoogle Scholar
• Sande MA., Korzeniowski OM., Allegro GM., Brennan RO., Zak O, Scheld WM. Intermittent or continuous therapy of experimental meningitis due to S. pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. Rev Infect Dis 1981; 3: 98–109
   PubMedGoogle Scholar
• Renneberg J, Walder M. Postantibiotic effects of imipenem, norfloxacin and amikacin in vitro and in vivo. Antimicrob Agents Chemother 1989; 33: 1714–1720
   PubMed Web of Science ®Google Scholar
• Ryan D, Cars O. Antibiotic assays in muscle: are conventional tissue levels misleading as indicators of the antibacterial activity?. Scand J Infect Dis 1980; 12: 307–309
   PubMed Web of Science ®Google Scholar
• Minguez F, Izquierdo J, Martin MM., Fuentes F, Prieto J. In vivo postantibiotic effect of isepamicin and other aminoglycosides in a thigh infection model in neutropenic mice. Chemotherapy 1992; 38: 179–184
   PubMed Web of Science ®Google Scholar
• Craig WA., Gudmundsson S. The postantibiotic effect. Antibiotics in laboratory medicine, 3rd edn., V Lorian. Williams and Wilkins, Baltimore 1991; 403–431
   Google Scholar
• Bustamante CI., Drusano GL., Tatem BA., Standiford HC. Postantibiotic effect of imipenem on P. aeruginosa. Antimicrob Agents Chemother 1984; 26: 678–682
   PubMed Web of Science ®Google Scholar
• Nadler HL., Pitkin DH., Sheikh W. The postantibiotic effect of meropenem and imipenem on selected bacteria. J Antimicrob Chemother 1989; 24(Suppl A)225–232
   PubMedGoogle Scholar
• Odenholt I, Isaksson B, Nilsson L, Cars O. Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 1989; 8: 136–141
   PubMed Web of Science ®Google Scholar
• Ferrara A, Dos-Santos C, Pirina P (1994) Postantibiotic effect of meropenem alone or in combination with gentamicin or sparfloxacin. Recent advances in chemotherapy. Proceedings of the 18th International Congress of Chemotherapy, Stockholm, 1993, 170–171
   Google Scholar
• Hanberger H, Nilsson LE., Svensson E, Nilsson M. Pharmacodynamic effects of imipenem and meropenem on non-growing and growing gram-negative bacteria: initial killing and postantibiotic effect. J Chemother 1993; 5(Suppl 1)119–120
   PubMedGoogle Scholar
• Debbia EA., Molinari G, Pesce A, Schito GC. Antibacterial activity of meropenem in combination with other drugs and postantibiotic effect. J Chemother 1993; 5(Suppl 1)114–117
   Google Scholar
• Nadler HL., Sheikh W. A comparison of the in vitro postantibiotic effect of meropenem and imipenem versus selected Enterobacteriaceae and other pathogens. Diagn Microbiol Infect Dis 1993; 17: 71–75
   PubMed Web of Science ®Google Scholar
• Odenholt-Tornqvist I. Studies on the postantibiotic sub-MIC effect of meropenem. J Antimicrob Chemother 1993; 31: 881–892
   PubMed Web of Science ®Google Scholar
• Wu PJ., Livermore DM. Response of chemostat cultures of Psendomonas aeruginosa to carbapenems and other β-lactams. J Antimicrob Chemother 1990; 25: 901–902
   Web of Science ®Google Scholar
• Martin MM., Fuentes F, Izquierdo J, Gomez-Lus ML., Pneto J. In vivo and in-vitro study of the postantibiotic effect of meropenem [Letter]. J Antimicrob Chemother 1993; 32: 917–918
   PubMed Web of Science ®Google Scholar
• Mattie H, Li-Chen Z. Antibiotic and postantibiotic effect (PAE) of meropenem (MP) and cloxacilin (CX) against S. aureus in vitro and in an experimental infection. Clin Infect Dis 1993; 17: 550
   Google Scholar
• Tanio T, Fukasawa M. In vitro and in vivo postantibiotic effect of meropenem. Chemotherapy (Japan) 1992; 40: 103–107
   Google Scholar
• Odenholt I, Holm SE., Cars O. Effects of benzylpenicillin on Streptococcus pyogenes during the postantibiotic phase in vitro. J Antimicrob Chemother 1989; 24: 147–156
   PubMed Web of Science ®Google Scholar
• Flückiger U, Segessenmann C, Gerber U. Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model. Antimicrob Agents Chemother 1991; 35: 1905–1910
   PubMed Web of Science ®Google Scholar
• Jones RN., Barry AL., Gavan RL., Washington JA., II. Susceptibility tests: microdilution and macrodilution broth procedures. Manual of clinical microbiology, EH. Lennette, A Balows, WJ. Hausler, HJ. Shadomy. American Society for Microbiology, Washington, DC 1985; 972–977
   Google Scholar
• Roosendaal R, Bakker-Woudenberg I AJM, van der Berghe-van Raffe M, Michel MF. Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats. Antimicrob Agents Chemother 1986; 30: 403–408
   PubMed Web of Science ®Google Scholar
• Majcherczyck PA., Livermore DM. Penicillin-binding Protein (PBP) 2 and the post-antibiotic effect of carbapenems. J Antimicrob Chemother 1990; 26: 593–594
   PubMed Web of Science ®Google Scholar
• MacKenzie FM., Gould IM., Chapman DG., Jason D. Postantibiotic effect of meropenem on members of the family Enterobacteriaceae determined by five methods. Antimicrob Agents Chemother 1994; 38: 2583–2589
   PubMed Web of Science ®Google Scholar
• MacKenzie FM., Gould IM. The postantibiotic effect. J Antimicrob Chemother 1993; 32: 519–537
   PubMed Web of Science ®Google Scholar
• Oshida T, Onta T, Nakanishi N, Matsishita T, Yamaguchi T. Activity of subminimal inhibitory concentrations of aspoxicillin in prolonging the postantibiotic effect against Staphylococcus aureus. J Antimicrob Chemother 1990; 26: 29–38
   PubMed Web of Science ®Google Scholar
• Odenholt-Tornqvist I, Löwdin E, Cars O. Postantibiotic sub-MIC effects for vancomycin, roxithromycin, sparfloxacin and amikacin. Antimicrob Agents Chemother 1992; 36: 1852–1858
   PubMed Web of Science ®Google Scholar
• Odenholt-Tornqvist I, Löwdin E, Cars O. Pharmacodynamic effects of subinhibitory concentrations of β-lactams antibiotics in vitro. Antimicrob Agents Chemother 1991; 35: 1834–1839
   PubMed Web of Science ®Google Scholar
• Vogelman B, Gudmundsson S, Leggett J, Turnidge J. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis 1988; 158: 831–847
   PubMed Web of Science ®Google Scholar